Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Collections
  • About
    • General information
    • Staff
    • Editorial board
    • Open access
    • Contact
  • CMAJ JOURNALS
    • CMAJ
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ Open
  • CMAJ JOURNALS
    • CMAJ
    • CJS
    • JAMC
    • JPN
CMAJ Open

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Collections
  • About
    • General information
    • Staff
    • Editorial board
    • Open access
    • Contact
  • RSS feeds
Research

Catastrophic drug coverage: utilization insights from the Ontario Trillium Drug Program

Mina Tadrous, Simon Greaves, Diana Martins, Muhammad M. Mamdani, David N. Juurlink and Tara Gomes
March 26, 2018 6 (1) E132-E138; DOI: https://doi.org/10.9778/cmajo.20170132
Mina Tadrous
Li Ka Shing Knowledge Institute (Tadrous, Gomes), St. Michael's Hospital; Institute for Clinical Evaluative Sciences (Tadrous, Greaves, Martins, Mamdani, Juurlink, Gomes); Leslie Dan Faculty of Pharmacy (Tadrous, Mamdani, Gomes), University of Toronto; Institute of Health Policy, Management and Evaluation (Mamdani, Juurlink, Gomes), University of Toronto; Li Ka Shing Centre for Healthcare Analytics Research and Training (Mamdani), St. Michael's Hospital; Sunnybrook Research Institute (Juurlink), Toronto, Ont.
PharmDPhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simon Greaves
Li Ka Shing Knowledge Institute (Tadrous, Gomes), St. Michael's Hospital; Institute for Clinical Evaluative Sciences (Tadrous, Greaves, Martins, Mamdani, Juurlink, Gomes); Leslie Dan Faculty of Pharmacy (Tadrous, Mamdani, Gomes), University of Toronto; Institute of Health Policy, Management and Evaluation (Mamdani, Juurlink, Gomes), University of Toronto; Li Ka Shing Centre for Healthcare Analytics Research and Training (Mamdani), St. Michael's Hospital; Sunnybrook Research Institute (Juurlink), Toronto, Ont.
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Diana Martins
Li Ka Shing Knowledge Institute (Tadrous, Gomes), St. Michael's Hospital; Institute for Clinical Evaluative Sciences (Tadrous, Greaves, Martins, Mamdani, Juurlink, Gomes); Leslie Dan Faculty of Pharmacy (Tadrous, Mamdani, Gomes), University of Toronto; Institute of Health Policy, Management and Evaluation (Mamdani, Juurlink, Gomes), University of Toronto; Li Ka Shing Centre for Healthcare Analytics Research and Training (Mamdani), St. Michael's Hospital; Sunnybrook Research Institute (Juurlink), Toronto, Ont.
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Muhammad M. Mamdani
Li Ka Shing Knowledge Institute (Tadrous, Gomes), St. Michael's Hospital; Institute for Clinical Evaluative Sciences (Tadrous, Greaves, Martins, Mamdani, Juurlink, Gomes); Leslie Dan Faculty of Pharmacy (Tadrous, Mamdani, Gomes), University of Toronto; Institute of Health Policy, Management and Evaluation (Mamdani, Juurlink, Gomes), University of Toronto; Li Ka Shing Centre for Healthcare Analytics Research and Training (Mamdani), St. Michael's Hospital; Sunnybrook Research Institute (Juurlink), Toronto, Ont.
PharmDMPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David N. Juurlink
Li Ka Shing Knowledge Institute (Tadrous, Gomes), St. Michael's Hospital; Institute for Clinical Evaluative Sciences (Tadrous, Greaves, Martins, Mamdani, Juurlink, Gomes); Leslie Dan Faculty of Pharmacy (Tadrous, Mamdani, Gomes), University of Toronto; Institute of Health Policy, Management and Evaluation (Mamdani, Juurlink, Gomes), University of Toronto; Li Ka Shing Centre for Healthcare Analytics Research and Training (Mamdani), St. Michael's Hospital; Sunnybrook Research Institute (Juurlink), Toronto, Ont.
MDPhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tara Gomes
Li Ka Shing Knowledge Institute (Tadrous, Gomes), St. Michael's Hospital; Institute for Clinical Evaluative Sciences (Tadrous, Greaves, Martins, Mamdani, Juurlink, Gomes); Leslie Dan Faculty of Pharmacy (Tadrous, Mamdani, Gomes), University of Toronto; Institute of Health Policy, Management and Evaluation (Mamdani, Juurlink, Gomes), University of Toronto; Li Ka Shing Centre for Healthcare Analytics Research and Training (Mamdani), St. Michael's Hospital; Sunnybrook Research Institute (Juurlink), Toronto, Ont.
MHScPhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF
Loading

Article Information

vol. 6 no. 1 E132-E138
DOI 
https://doi.org/10.9778/cmajo.20170132
PubMed 
29581101
History 
  • Published online March 26, 2018.
Copyright & Usage 
Copyright 2018, Joule Inc. or its licensors

Author Information

  1. Mina Tadrous, PharmD, PhD,
  2. Simon Greaves, MSc,
  3. Diana Martins, MSc,
  4. Muhammad M. Mamdani, PharmD, MPH,
  5. David N. Juurlink, MD, PhD,
  6. Tara Gomes, MHSc, PhD
  1. Affiliations: Li Ka Shing Knowledge Institute (Tadrous, Gomes), St. Michael's Hospital; Institute for Clinical Evaluative Sciences (Tadrous, Greaves, Martins, Mamdani, Juurlink, Gomes); Leslie Dan Faculty of Pharmacy (Tadrous, Mamdani, Gomes), University of Toronto; Institute of Health Policy, Management and Evaluation (Mamdani, Juurlink, Gomes), University of Toronto; Li Ka Shing Centre for Healthcare Analytics Research and Training (Mamdani), St. Michael's Hospital; Sunnybrook Research Institute (Juurlink), Toronto, Ont.
  1. Correspondence to:
    Mina Tadrous, tadrousm{at}smh.ca
View Full Text

Usage statistics: March 2018 to September 2025

AbstractFullPdf
Mar 2018121727122
Apr 20185722149
May 20182110919
Jun 2018227013
Jul 201816389
Aug 2018175010
Sep 2018316910
Oct 20182436215
Nov 20182824421
Dec 2018262689
Jan 2019152691
Feb 2019103134
Mar 20191126815
Apr 20191126210
May 2019102302
Jun 2019161686
Jul 2019111572
Aug 201981639
Sep 201971592
Oct 2019132149
Nov 2019111785
Dec 2019281583
Jan 20204304
Feb 20209356
Mar 202012321
Apr 20207226
May 20205312
Jun 2020692
Jul 20209123
Aug 202013124
Sep 20201075
Oct 202027138
Nov 20208174
Dec 202013197
Jan 20218203
Feb 20218272
Mar 202114187
Apr 20217220
May 2021102410
Jun 20213185
Jul 20211308
Aug 20211247
Sep 202132214
Oct 202132925
Nov 202103120
Dec 2021132610
Jan 202231610
Feb 20222309
Mar 2022123120
Apr 202273413
May 202211412
Jun 202233227
Jul 20220222
Aug 20222237
Sep 20225179
Oct 20221255
Nov 20222337
Dec 20221127
Jan 20235196
Feb 20231172
Mar 2023063
Apr 20231156
May 2023042
Jun 20232157
Jul 20231104
Aug 20232134
Sep 20231259
Oct 202334115
Nov 20232618
Dec 202317046
Jan 2024428250
Feb 20242178
Mar 202455318
Apr 202454030
May 202442712
Jun 202444013
Jul 2024103618
Aug 202433021
Sep 202434319
Oct 202487122
Nov 202427125
Dec 202414432
Jan 202512223
Feb 202543520
Mar 202594939
Apr 202517232
May 202515625
Jun 202514925
Jul 2025970934
Aug 202525844
Sep 202511210
PreviousNext
Back to top

In this issue

CMAJ Open: 6 (1)
Vol. 6, Issue 1
1 Jan 2018
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ Open.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Catastrophic drug coverage: utilization insights from the Ontario Trillium Drug Program
(Your Name) has sent you a message from CMAJ Open
(Your Name) thought you would like to see the CMAJ Open web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Catastrophic drug coverage: utilization insights from the Ontario Trillium Drug Program
Mina Tadrous, Simon Greaves, Diana Martins, Muhammad M. Mamdani, David N. Juurlink, Tara Gomes
Jan 2018, 6 (1) E132-E138; DOI: 10.9778/cmajo.20170132

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Catastrophic drug coverage: utilization insights from the Ontario Trillium Drug Program
Mina Tadrous, Simon Greaves, Diana Martins, Muhammad M. Mamdani, David N. Juurlink, Tara Gomes
Jan 2018, 6 (1) E132-E138; DOI: 10.9778/cmajo.20170132
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • Projected impact of biosimilar substitution policies on drug use and costs in Ontario, Canada: a cross-sectional time series analysis
  • Characteristics of high-drug-cost beneficiaries of public drug plans in 9 Canadian provinces: a cross-sectional analysis
  • Google Scholar

Similar Articles

Collections

  • Nonclinical
    • Health Policy
      • Health care funding outside of medicare
    • Health Economics - see also Medicare
  • Clinical
    • Drugs
      • Other drug use

Content

  • Current issue
  • Past issues
  • Collections

About

  • General Information
  • Staff
  • Editorial Board
  • Advisory Panel
  • Contact Us
  • Reprints
  • Copyright and Permissions
CMAJ Group

Copyright 2025, CMA Impact Inc. or its licensors. All rights reserved. ISSN 2291-0026

All editorial matter in CMAJ OPEN represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected].

CMA Civility, Accessibility, Privacy

 

 

Powered by HighWire